NDC 80425-0384-03 - IBUPROFEN AND FAMOTIDINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0384
- Requested NDC
- 80425-0384-03
- Package NDCs from labels
- 80425-0384-1, 80425-0384-2, 80425-0384-3, 80425-0384-03
- Manufacturer
- Advanced Rx Pharmacy of Tennessee, LLC
- Effective date
- 2024-04-23
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| IBUPROFEN AND FAMOTIDINE - Advanced Rx Pharmacy of Tennessee, LLC | Advanced Rx Pharmacy of Tennessee, LLC | 2024-04-23 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80425-0384-1 | IBUPROFEN AND FAMOTIDINE | 30 in 1 BOTTLE | TABLET | 30 | 1 | |
| 80425-0384-2 | IBUPROFEN AND FAMOTIDINE | 60 in 1 BOTTLE | TABLET | 60 | 1 | |
| 80425-0384-3 | IBUPROFEN AND FAMOTIDINE | 90 in 1 BOTTLE | TABLET | 90 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 80425-0384 | IBUPROFEN AND FAMOTIDINE TABLET [ADVANCED RX PHARMACY OF TENNESSEE, LLC] | 1 | Current NDC, 3 package rows | 20240426_16c8b0db-37d0-99d9-e063-6394a90ac31b.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 80425-0384-1 | EA - Each | 80425-0384 | 76e60705-5101-43cb-8730-11d39c68e1f5 | 1 | 2024-06-10 |
| 80425-0384-2 | EA - Each | 80425-0384 | ccfa16aa-ab0a-4739-bb06-14b214400e27 | 1 | 2024-06-10 |
| 80425-0384-3 | EA - Each | 80425-0384 | 4d802630-9552-417f-ab5b-8a83770799ef | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | fcc992bf-95db-40c7-a6aa-e346a9b2a914 | 2026-11-02 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| equate ibuprofen | IBUPROFEN | Wal-Mart Stores Inc | 307b0257-d636-416b-828a-f901782e9b10 | 2026-11-02 | Warnings | WK2XYI10QM |
| Signature Care Ibuprofen | IBUPROFEN | Safeway | 93edca03-fdf1-453f-8efe-5f0b8eef41e4 | 2026-10-30 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Kareway Product, Inc. | 570f8acc-ed6d-e789-e063-6294a90ab128 | 2026-10-29 | Warnings | WK2XYI10QM |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | REMEDYREPACK INC. | b969bb72-66de-47ce-9d77-64d029e1a5c9 | 2026-10-29 | Boxed warning, Warnings, Adverse reactions | 1100066 WK2XYI10QM 5QZO15J2Z8 |
| FAMOTIDINE | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | a3b50576-cd40-4f7e-9506-bd0a61988424 | 2026-10-29 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Ibuprofen Oral | IBUPROFEN ORAL | NuCare Pharmaceuticals, Inc. | 5f02878c-84c6-bf91-e063-6294a90aaf6a | 2026-10-29 | Warnings | WK2XYI10QM |
| Motrin IB | IBUPROFEN | Kenvue Brands LLC | d21129f8-4d96-4e36-bc39-a534306dd77e | 2026-10-28 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | REMEDYREPACK INC. | 1b1e1578-3ff5-47a4-a53b-c19512d0f953 | 2026-10-28 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | BI-MART | 34440532-03e1-4feb-b3e2-dab869edeb15 | 2026-10-28 | Warnings | WK2XYI10QM |
| Famotidine | FAMOTIDINE | PD-Rx Pharmaceuticals, Inc. | 002875d2-8c30-2d2e-e063-6294a90ae01e | 2026-10-28 | Warnings, Adverse reactions | 5QZO15J2Z8 |
| Ibuprofen | IBUPROFEN | Famora Inc | 790d2917-733b-4b59-933c-2701dbf0ee16 | 2026-10-27 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | RETAIL BUSINESS SERVICES , LLC. | 8f9f099a-ee59-0b9a-e053-2a95a90a2fe1 | 2026-10-27 | Warnings | WK2XYI10QM |
| ibuprofen | IBUPROFEN | Meijer Distribution Inc | 66b19ed1-6cf9-4705-82cd-02f23c6379e7 | 2026-10-27 | Warnings | WK2XYI10QM |
| Glycerin | GLYCERIN | Chain Drug Marketing Association Inc. | 424d91f0-ecf9-6d9b-e063-6394a90a8006 | 2026-10-26 | Warnings | PDC6A3C0OX |
| Family Wellness HEMORRHOID | GLYCERIN, PETROLATUM, PHENYLEPHRINE HCL, PRAMOXINE HCL | FAMILY DOLLAR (Family Wellness) | 16ceb129-5c0a-428a-a867-cfbbb08bb62a | 2026-10-26 | Warnings | PDC6A3C0OX |
| Ibuprofen and famotidine | IBUPROFEN AND FAMOTIDINE | Bryant Ranch Prepack | ee69d3cb-dc95-410c-a7c8-6623073a923d | 2026-10-26 | Boxed warning, Warnings, Adverse reactions | 1100066 WK2XYI10QM 5QZO15J2Z8 |
| Ibuprofen | IBUPROFEN | Walgreen Company | c118b290-f821-4e73-906e-8a93edaf34e4 | 2026-10-26 | Warnings | WK2XYI10QM |
| Optase | GLYCERIN | Scope Health Inc | d81c1a4f-87b0-ee8c-e053-2995a90af9e5 | 2026-10-25 | Warnings | PDC6A3C0OX |
| Optase | GLYCERIN | Scope Health Inc | 9e96976b-2990-79e0-e053-2995a90a0f29 | 2026-10-25 | Warnings | PDC6A3C0OX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.